Sabita Sankar

Summary

Affiliation: Celgene Corporation
Country: USA

Publications

  1. ncbi request reprint IKK-i signals through IRF3 and NFkappaB to mediate the production of inflammatory cytokines
    Sabita Sankar
    Experimental Therapeutics Inflammation, Celgene, 4550 Towne Centre Court, San Diego, CA 92121, United States
    Cell Signal 18:982-93. 2006
  2. doi request reprint CC-4047 promotes Th1 cell differentiation and reprograms polarized human Th2 cells by enhancing transcription factor T-bet
    Weiming Xu
    Celgene Corporation, 4550 Towne Centre Court, San Diego, CA 92121, USA
    Clin Immunol 128:392-9. 2008

Collaborators

  • Weiming Xu
  • Brydon L Bennett
  • David R Webb
  • Maria Celeridad

Detail Information

Publications2

  1. ncbi request reprint IKK-i signals through IRF3 and NFkappaB to mediate the production of inflammatory cytokines
    Sabita Sankar
    Experimental Therapeutics Inflammation, Celgene, 4550 Towne Centre Court, San Diego, CA 92121, United States
    Cell Signal 18:982-93. 2006
    ..We also identified STAT1, Tyk2, and JAK1 as secondary mediators of IKK-i signaling as a result of interferon beta production in these cells...
  2. doi request reprint CC-4047 promotes Th1 cell differentiation and reprograms polarized human Th2 cells by enhancing transcription factor T-bet
    Weiming Xu
    Celgene Corporation, 4550 Towne Centre Court, San Diego, CA 92121, USA
    Clin Immunol 128:392-9. 2008
    ....